Potential utility of anti‐TNF drugs in synovial chondromatosis associated with ankylosing spondylitis

Abstract

We describe a previously unreported association of ankylosing spondylitis with synovial chondromatosis, and briefly review previously reported cases and treatment of synovial chondromatosis in patients with other immune-mediated inflammatory arthritides. A 20-year-old man with ankylosing spondylitis whose axial disease was

Synovial Chondromatosis of Hip Joint in a Patient with Ankylosing Spondylitis: A Case Report

“…In a few reported cases of synovial chondromatosis with inflammatory arthritis, invasive treatment was mostly given when a single joint was involved. 2 - 4 However, in another study, synovial chondromatosis of the knee associated with axial ankylosing spondylitis, management was done with the biologic agent etanercept which provided long-term symptomatic relief but there was no reduction in the number of loose bodies at two years follow up. 4 …”

“… 2 - 4 However, in another study, synovial chondromatosis of the knee associated with axial ankylosing spondylitis, management was done with the biologic agent etanercept which provided long-term symptomatic relief but there was no reduction in the number of loose bodies at two years follow up. 4 …”

“… 2 , 3 However, synovial chondromatosis has been reported only once before in association with ankylosing spondylitis to the best of our knowledge. 4 We hereby report a 52-year-old male who was diagnosed with synovial chondromatosis of the hip joint with axial ankylosing spondylitis and was managed operatively.…”